Profund Advisors LLC Sells 333 Shares of Cigna Group $CI

Profund Advisors LLC trimmed its position in Cigna Group (NYSE:CI) by 8.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 3,412 shares of the health services provider’s stock after selling 333 shares during the period. Profund Advisors LLC’s holdings in Cigna Group were worth $1,128,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of CI. Brighton Jones LLC grew its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. Florida Financial Advisors LLC raised its holdings in Cigna Group by 10.7% in the 1st quarter. Florida Financial Advisors LLC now owns 1,018 shares of the health services provider’s stock valued at $335,000 after buying an additional 98 shares during the last quarter. Signaturefd LLC boosted its position in Cigna Group by 16.5% during the 1st quarter. Signaturefd LLC now owns 6,487 shares of the health services provider’s stock worth $2,134,000 after buying an additional 921 shares during the period. Catalyst Financial Partners LLC grew its holdings in Cigna Group by 10.0% during the 1st quarter. Catalyst Financial Partners LLC now owns 1,102 shares of the health services provider’s stock worth $363,000 after acquiring an additional 100 shares during the last quarter. Finally, Sigma Planning Corp increased its position in Cigna Group by 2.4% in the 1st quarter. Sigma Planning Corp now owns 2,039 shares of the health services provider’s stock valued at $671,000 after acquiring an additional 48 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Up 3.7%

NYSE:CI opened at $267.82 on Wednesday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $71.54 billion, a price-to-earnings ratio of 14.62, a PEG ratio of 0.88 and a beta of 0.44. The firm has a fifty day simple moving average of $291.71 and a two-hundred day simple moving average of $302.28.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is 26.64%.

Insiders Place Their Bets

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft cut their price target on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. Robert W. Baird set a $372.00 target price on Cigna Group in a research report on Thursday, August 14th. Guggenheim reduced their price target on Cigna Group from $350.00 to $309.00 in a research report on Friday, October 31st. Truist Financial decreased their price target on Cigna Group from $375.00 to $310.00 in a research note on Friday, October 31st. Finally, Cowen restated a “buy” rating on shares of Cigna Group in a research report on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $339.73.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.